<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03179813</url>
  </required_header>
  <id_info>
    <org_study_id>44657315.4.0000.0075</org_study_id>
    <nct_id>NCT03179813</nct_id>
  </id_info>
  <brief_title>Topical Hydrocortisone for Pain and Edema Control After Third Molar Surgery</brief_title>
  <official_title>Topical Hydrocortisone for Pain and Edema Control After Third Molar Surgery: a Clinical, Crossover, Randomized, Double-blind, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators set out to develop a clinical trial in order to test the topical use of
      hydrocortisone as a intraoperative irrigant solution. As this route of administration as well
      as being low cost and not add new steps to the surgical procedure, can contribute to an
      improved quality of life in the postoperative period of patients undergoing extraction of
      third molars.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Third molars are the teeth with a higher prevalence of failure in eruption and surgery for
      extraction of these impacted teeth is one of the most commonly procedures performed by the
      oral and maxillofacial surgeon. In most cases these are not traumatic procedures, however
      factors such as patient age, habits, degree of tooth impaction and surgeon experience can
      influence the surgical trauma and therefore the postoperative period could include swelling
      and pain of varying magnitudes which can significantly affect the patient's quality of life.

      The study is designed as a prospective, randomized, placebo-controlled, split-mouth crossover
      trial. All the patients will be informed of the experimental methodology and signed a
      institutionally approved consent form. The study is been conducted in compliance with
      Declaration of Helsinki (1989), and was revised by the Institutional Ethical Committee
      (protocol 1.167.908).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Actual">March 1, 2018</completion_date>
  <primary_completion_date type="Actual">January 3, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Edema</measure>
    <time_frame>From the preoperative moment to the second postoperative day</time_frame>
    <description>Change in edema measures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>Up to 2 days (amount of analgesic medication intake form the immediate postoperative moment to the second postoperative day)</time_frame>
    <description>Quantitative evaluation (amount of analgesic medication intake)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>Up to 2 days (from the immediate postoperative moment to the second postoperative day)</time_frame>
    <description>Subjective evaluation - Visual Analog Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Impacted Third Molar Tooth</condition>
  <arm_group>
    <arm_group_label>Hydrocortisone group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraoperative topical use of hydrocortisone as a irrigation solution in third molar surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intraoperative irrigation with saline solution.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hydrocortisone</intervention_name>
    <description>During the third molar extraction the hydrocortisone solution will be used in the test group</description>
    <arm_group_label>Hydrocortisone group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>During the third molar extraction the saline solution will be used in the control group</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Health patients of any sex, with symmetric bilateral bone-impacted mandibular third
             molars requiring surgical removal, and with no history of allergy to the drugs used in
             this study.

        Exclusion Criteria:

          -  Use of analgesic or anti-inflammatory drugs 24 hours before the surgery.

          -  Pregnant or breastfeeding patients,

          -  Use of other drugs beyond of that one's prescribed by the researchers;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Vitor Pereira Rodrigues</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <zip>04105000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Ngeow WC, Lim D. Do Corticosteroids Still Have a Role in the Management of Third Molar Surgery? Adv Ther. 2016 Jul;33(7):1105-39. doi: 10.1007/s12325-016-0357-y. Epub 2016 Jun 10. Review.</citation>
    <PMID>27287853</PMID>
  </reference>
  <reference>
    <citation>Herrera-Briones FJ, Prados Sánchez E, Reyes Botella C, Vallecillo Capilla M. Update on the use of corticosteroids in third molar surgery: systematic review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Nov;116(5):e342-51. doi: 10.1016/j.oooo.2012.02.027. Epub 2012 Aug 17. Review.</citation>
    <PMID>22902498</PMID>
  </reference>
  <reference>
    <citation>Grossi GB, Maiorana C, Garramone RA, Borgonovo A, Beretta M, Farronato D, Santoro F. Effect of submucosal injection of dexamethasone on postoperative discomfort after third molar surgery: a prospective study. J Oral Maxillofac Surg. 2007 Nov;65(11):2218-26.</citation>
    <PMID>17954317</PMID>
  </reference>
  <reference>
    <citation>Ceccheti MM, Negrato GV, Peres MP, Deboni MC, Naclério-Homem Mda G. Analgesic and adjuvant anesthetic effect of submucosal tramadol after mandibular third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Mar;117(3):e249-54. doi: 10.1016/j.oooo.2012.05.015. Epub 2012 Sep 12.</citation>
    <PMID>22981094</PMID>
  </reference>
  <reference>
    <citation>Pourdanesh F, Khayampour A, Jamilian A. Therapeutic effects of local application of dexamethasone during bilateral sagittal split ramus osteotomy surgery. J Oral Maxillofac Surg. 2014 Jul;72(7):1391-4. doi: 10.1016/j.joms.2013.12.025. Epub 2014 Jan 15.</citation>
    <PMID>24576440</PMID>
  </reference>
  <reference>
    <citation>Mahmoud Hashemi H, Mohammadi F, Hasheminasab M, Mahmoud Hashemi A, Zahraei S, Mahmoud Hashemi T. Effect of low-concentration povidone iodine on postoperative complications after third molar surgery: a pilot split-mouth study. J Oral Maxillofac Surg. 2015 Jan;73(1):18-21. doi: 10.1016/j.joms.2014.06.454. Epub 2014 Jul 5.</citation>
    <PMID>25249172</PMID>
  </reference>
  <reference>
    <citation>UStün Y, Erdogan O, Esen E, Karsli ED. Comparison of the effects of 2 doses of methylprednisolone on pain, swelling, and trismus after third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Nov;96(5):535-9.</citation>
    <PMID>14600686</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2017</study_first_submitted>
  <study_first_submitted_qc>June 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2017</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Vitor Pereira Rodrigues</investigator_full_name>
    <investigator_title>PhD candidate</investigator_title>
  </responsible_party>
  <keyword>hydrocortisone</keyword>
  <keyword>third molar</keyword>
  <keyword>oral surgery</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>edema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth, Impacted</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

